Syed Yousuf Zafar
Adjunct Professor in the Department of Medicine
Dr. Zafar is a gastrointestinal medical oncologist and Associate Professor of Medicine, Public Policy, and Population Health Science at the Duke Cancer Institute and Duke-Margolis Center for Health Policy. He serves as Director of Healthcare Innovation at the Duke Cancer Institute. Dr. Zafar also serves as Clinical Associate Director of Duke Forge (Health Data Science Center). Dr. Zafar is considered an international expert in identifying and intervening upon the financial burden of cancer care. His research explores ways to improve cancer care delivery with a primary focus on improving the value of cancer treatment from both patient-focused and policy perspectives.
Dr. Zafar speaks internationally on his research and cancer care delivery. He has over 100 publications in top peer-reviewed journals including the New England Journal of Medicine, the Journal of Clinical Oncology, and JAMA Oncology. His research has been funded by the National Institutes of Health and the American Cancer Society, among others. His work has been covered by national media outlets including New York Times, Forbes, Wall Street Journal, NPR, and Washington Post. He is a Fellow of the American Society of Clinical Oncology.
Current Appointments & Affiliations
- Adjunct Professor in the Department of Medicine, Medicine, Medical Oncology, Medicine 2022
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2005
- Affiliate, Duke Global Health Institute, Duke Global Health Institute, University Institutes and Centers 2011
- Member in the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 2012
- Core Faculty Member, Duke-Margolis Center for Health Policy, Duke - Margolis Center For Health Policy, Initiatives 2019
- Associate of the Duke Initiative for Science & Society, Duke Science & Society, Initiatives 2020
Contact Information
- Duke Box 3505, Durham, NC 27710
- Seeley G. Mudd Building, Rm 43, 10 Bryan Searle Dr., DUMC 3505, Durham, NC 27710
-
yousuf.zafar@duke.edu
(919) 684-8111
-
twitter
- Background
-
Education, Training, & Certifications
- Fellow in Hematology-Oncology, Medicine, Duke University 2005 - 2008
- Resident, Medicine, University of Cincinnati 2002 - 2005
- M.D., The University of Toledo 2002
-
Previous Appointments & Affiliations
- Associate Professor in the Sanford School of Public Policy, Sanford School of Public Policy, Duke University 2016 - 2021
- Associate Professor in Population Health Sciences, Population Health Sciences, Basic Science Departments 2019 - 2021
- Professor of Medicine, Medicine, Medical Oncology, Medicine 2021
- Associate Professor of Medicine, Medicine, Medical Oncology, Medicine 2019 - 2021
- Associate Professor of Medicine, Medicine, Medical Oncology, Medicine 2014 - 2019
- Associate Professor in Population Health Sciences, Population Health Sciences, Basic Science Departments 2018 - 2019
- Assistant Professor of Medicine, Medicine, Medical Oncology, Medicine 2010 - 2014
- Medical Instructor in the Department of Medicine, Medicine, Medical Oncology, Medicine 2008 - 2010
- Instructor, Temporary in the Department of Medicine, Medicine, Medical Oncology, Medicine 2008
-
Leadership & Clinical Positions at Duke
-
Director of Healthcare Innovation, Duke Cancer Institute
Director, Center for Applied Cancer Health Policy
Co-Leader, Health Care Delivery Focus Area, Cancer Control and Population Sciences
-
Director of Healthcare Innovation, Duke Cancer Institute
- Recognition
-
In the News
-
JUN 6, 2019 WBUR -
JUN 6, 2019 LA Times -
FEB 21, 2019 New York Times -
AUG 11, 2017 Duke Health News -
AUG 10, 2017 US News & World Report -
AUG 10, 2017 Forbes -
AUG 10, 2017 NPR -
MAY 19, 2017 Duke Research Blog -
JUN 6, 2016 -
JUL 2, 2015 The Daily Mail -
JUL 2, 2015 The Daily Mail -
JUL 1, 2015 Duke Today -
JUL 1, 2015 -
DEC 18, 2014 Duke Today -
DEC 18, 2014 -
JUN 14, 2013 New York Times -
JUN 14, 2013 New York Times
-
-
Awards & Honors
- Expertise
-
Subject Headings
- Academic Medical Centers
- Adenocarcinoma
- Adult
- Africa
- Age Factors
- Aged
- Aged, 80 and over
- Ambulatory Care
- Ampulla of Vater
- Angiogenesis Inhibitors
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents
- Antineoplastic Combined Chemotherapy Protocols
- Attitude of Health Personnel
- Bevacizumab
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Cardiovascular Diseases
- Caregivers
- Chemoradiotherapy, Adjuvant
- Clinical Trials as Topic
- Cognition Disorders
- Cohort Studies
- Colorectal Neoplasms
- Common Bile Duct Neoplasms
- Communication
- Comorbidity
- Comparative Effectiveness Research
- Comprehensive Health Care
- Consensus
- Continental Population Groups
- Cooperative Behavior
- Cost Control
- Cost of Illness
- Cost-Benefit Analysis
- Data Collection
- Decision Making
- Decision Support Techniques
- Delivery of Health Care
- Delivery of Health Care, Integrated
- Delphi Technique
- Demography
- Depression
- Disclosure
- Disease-Free Survival
- Drug Administration Schedule
- Drug Approval
- Early Detection of Cancer
- Epidemiologic Research Design
- Evidence-Based Medicine
- Evidence-Based Practice
- Family
- Fatigue
- Fee-for-Service Plans
- Female
- Financial Support
- Financing, Personal
- Follow-Up Studies
- Gastrointestinal Diseases
- Gastrointestinal Neoplasms
- Glutamates
- Guanine
- Guideline Adherence
- Guilt
- Health Care Costs
- Health Care Rationing
- Health Expenditures
- Health Priorities
- Health Services Accessibility
- Health Services Needs and Demand
- Health Services Research
- Health Status
- Hospitals, Veterans
- Humans
- Hydroxamic Acids
- Hypocalcemia
- Hypokalemia
- Immunohistochemistry
- Immunosuppressive Agents
- Income
- Injections, Intravenous
- Insurance Carriers
- Internal-External Control
- Kaplan-Meier Estimate
- Leukocytes, Mononuclear
- Logistic Models
- Long-Term Care
- Male
- Medical History Taking
- Medical Oncology
- Microsatellite Instability
- Middle Aged
- Motivation
- Mutation
- Neoplasm Grading
- Neoplasm Metastasis
- Neoplasm Proteins
- Neoplasm Staging
- Neoplasms
- Organizational Innovation
- Oxaliplatin
- Pain
- Pain Measurement
- Palliative Care
- Pancreaticoduodenectomy
- Patient Preference
- Patient Satisfaction
- Patient-Centered Care
- Patients
- Perception
- Personnel, Hospital
- Physician's Practice Patterns
- Pilot Projects
- Prevalence
- Prognosis
- Program Development
- Program Evaluation
- Prospective Studies
- Protein Kinase Inhibitors
- Pyrimidines
- Quality Assurance, Health Care
- Quality Improvement
- Quality Indicators, Health Care
- Quality of Health Care
- Quality of Life
- Questionnaires
- Randomized Controlled Trials as Topic
- Reference Standards
- Regional Health Planning
- Registries
- Regression Analysis
- Reproducibility of Results
- Research
- Research Design
- Retrospective Studies
- Sarcoma, Kaposi
- Self Concept
- Sirolimus
- Social Stigma
- Socioeconomic Factors
- Specialization
- Stereotyping
- Stress, Psychological
- Survival Rate
- Survivors
- Terminology as Topic
- Therapeutics
- Thiazoles
- Treatment Outcome
- Tumor Markers, Biological
- United States
- United States Department of Veterans Affairs
- Veterans
- Veterans Health
- Withholding Treatment
- Young Adult
-
Global Scholarship
- Research
-
Selected Grants
- Improving outcomes of patients with advanced prostate cancer through a better understanding of provider decision-making awarded by National Institutes of Health 2022 - 2027
- Using Modifiable Risk Factors to Predict Inferior Care and Survival after Breast Cancer Diagnosis: A Novel Approach to Addressing Health Disparities awarded by National Institutes of Health 2019 - 2024
- Improving Advance Care Planning in Oncology: A Pragmatic, Cluster-Randomized Trial Integrating Patient Videos and Clinician Communication Training awarded by Dana-Farber Cancer Institute 2018 - 2023
- Couple Communication in Cancer: A Multi-method Examination awarded by Arizona State University 2016 - 2022
- Examining Best Practices for Factoring Out-Of-Pocket Expenses into Patients' Health Care Decisions awarded by Patrick & Catherine Weldon Donaghue Medical Research Foundation 2018 - 2021
- PAPNavigator STTR (Fast-Track) awarded by Vivor, LLC 2016 - 2019
- Using AACT - to answer Oncology landscape portfolio of open trials awarded by American Cancer Society Cancer Action Network 2017 - 2018
- Financial Assistance, Navigation, and Communication Education (FinANCE): Development and pilot testing of a web-based financial toxicity intervention awarded by Brigham and Women's Hospital 2013 - 2015
- Does Comparative Effectiveness Research Promote Rationing or Rational Cancer Care? awarded by Greenwall Foundation 2013 - 2014
- CTSA KL2 awarded by National Institutes of Health 2006 - 2013
- Duke CTSA-KL2 awarded by National Institutes of Health 2006 - 2012
-
External Relationships
- Change Healthcare
- Copernicus Group IRB
- Family Reach Foundation
- McKesson Corporation
- Quintiles
- Shattuck Labs
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Fayanju, O. M., Oyekunle, T., Thomas, S. M., Ingraham, K. L., Fish, L. J., Greenup, R. A., … Barrett, N. J. (2022). Modifiable patient-reported factors associated with cancer-screening knowledge and participation in a community-based health assessment. Am J Surg. https://doi.org/10.1016/j.amjsurg.2022.10.059Full Text Link to Item
-
Merz, A., Mohamed, A., Corbett, C., Herring, K., Hildenbrand, J., Locke, S. C., … LeBlanc, T. W. (2022). A single-site pilot feasibility randomized trial of a supportive care mobile application intervention for patients with advanced cancer and caregivers. Support Care Cancer, 30(10), 7853–7861. https://doi.org/10.1007/s00520-022-07224-xFull Text Link to Item
-
Porter, L. S., Ramos, K., Baucom, D. H., Steinhauser, K., Erkanli, A., Strauman, T. J., … Keefe, F. J. (2022). Evaluating a couple communication skills training (CCST) intervention for advanced cancer: study protocol for a randomized controlled trial. Trials, 23(1), 712. https://doi.org/10.1186/s13063-022-06656-4Full Text Link to Item
-
Sloan, C. E., Gutterman, S., Davis, J. K., Campagna, A., Pollak, K. I., Barks, M. C., … Ubel, P. A. (2022). How can healthcare organizations improve cost-of-care conversations? A qualitative exploration of clinicians' perspectives. Patient Educ Couns, 105(8), 2708–2714. https://doi.org/10.1016/j.pec.2022.04.005Full Text Link to Item
-
Chino, F., Carroll, A., Sanger-Katz, M., Dusetzina, S. B., & Zafar, S. Y. (2022). Communicating Research to Non-Researcher Audiences: A Panel Discussion From the National Cancer Institute's Future of Cancer Health Economics Research Conference. J Natl Cancer Inst Monogr, 2022(59), 64–67. https://doi.org/10.1093/jncimonographs/lgab021Full Text Link to Item
-
Jazowski, S. A., Wilson, L., Dusetzina, S. B., Zafar, S. Y., & Zullig, L. L. (2022). Association of High-Deductible Health Plan Enrollment With Spending on and Use of Lenalidomide Therapy Among Commercially Insured Patients With Multiple Myeloma. Jama Netw Open, 5(6), e2215720. https://doi.org/10.1001/jamanetworkopen.2022.15720Full Text Link to Item
-
Shah, K., Zafar, S. Y., & Chino, F. (2022). Role of financial toxicity in perpetuating health disparities. Trends Cancer, 8(4), 266–268. https://doi.org/10.1016/j.trecan.2021.12.007Full Text Link to Item
-
Zullig, L. L., Shahsahebi, M., Neely, B., Hyslop, T., Avecilla, R. A. V., Griffin, B. M., … Oeffinger, K. C. (2021). Low-touch, team-based care for co-morbidity management in cancer patients: the ONE TEAM randomized controlled trial. Bmc Fam Pract, 22(1), 234. https://doi.org/10.1186/s12875-021-01569-8Full Text Link to Item
-
Tarnasky, A. M., Tran, G. N., Nicolla, J., Friedman, F. A. P., Wolf, S., Troy, J. D., … Zafar, S. Y. (2021). Mobile Application to Identify Cancer Treatment-Related Financial Assistance: Results of a Randomized Controlled Trial. Jco Oncol Pract, 17(10), e1440–e1449. https://doi.org/10.1200/OP.20.00757Full Text Link to Item
-
Jazieh, A.-R., Jradi, H., Da’ar, O. B., Alkaiyat, M., Zafar, Y., & Alolayan, A. (2021). Developing, Implementing, and Validating a Social Toxicity Assessment Tool of Cancer. Jco Glob Oncol, 7, 1522–1528. https://doi.org/10.1200/GO.21.00170Full Text Link to Item
-
Slavin, S. D., Khera, R., Zafar, S. Y., Nasir, K., & Warraich, H. J. (2021). Financial burden, distress, and toxicity in cardiovascular disease. Am Heart J, 238, 75–84. https://doi.org/10.1016/j.ahj.2021.04.011Full Text Link to Item
-
Oshima, S. M., Tait, S. D., Rushing, C., Lane, W., Hyslop, T., Offodile, A. C., … Fish, L. J. (2021). Patient Perspectives on the Financial Costs and Burdens of Breast Cancer Surgery. Jco Oncol Pract, 17(6), e872–e881. https://doi.org/10.1200/OP.20.00780Full Text Link to Item
-
Strickler, J. H., Rushing, C. N., Uronis, H. E., Morse, M. A., Niedzwiecki, D., Blobe, G. C., … Hurwitz, H. I. (2021). Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer. Oncologist, 26(6), 465-e917. https://doi.org/10.1002/onco.13678Full Text Link to Item
-
Kelly, R. J., Ajani, J. A., Kuzdzal, J., Zander, T., Van Cutsem, E., Piessen, G., … CheckMate 577 Investigators, . (2021). Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer. N Engl J Med, 384(13), 1191–1203. https://doi.org/10.1056/NEJMoa2032125Full Text Link to Item
-
Bradley, C. J., Yabroff, K. R., Zafar, S. Y., & Shih, Y.-C. (2021). Time to add screening for financial hardship as a quality measure? Ca Cancer J Clin, 71(2), 100–106. https://doi.org/10.3322/caac.21653Full Text Link to Item
-
Hussaini, S. M. Q., Chino, F., Rushing, C., Samsa, G., Altomare, I., Nicolla, J., … Zafar, S. Y. (2021). Does Cancer Treatment-Related Financial Distress Worsen Over Time? N C Med J, 82(1), 14–20. https://doi.org/10.18043/ncm.82.1.14Full Text Link to Item
-
Zafar, S. Y. (2020). Crowdfunded Cancer Care-A Reflection on Health Care Delivery in the US. Jama Netw Open, 3(12), e2027191. https://doi.org/10.1001/jamanetworkopen.2020.27191Full Text Link to Item
-
Lou, E., Beg, M. S., Bergsland, E., Eng, C., Khorana, A. A., Kopetz, S., … Zafar, S. Y. (2020). Reply to S. Boutayeb et al. Jco Oncol Pract, 16(8), 525. https://doi.org/10.1200/OP.20.00394Full Text Link to Item
-
Moss, H. A., Wu, J., Kaplan, S. J., & Zafar, S. Y. (2020). The Affordable Care Act's Medicaid Expansion and Impact Along the Cancer-Care Continuum: A Systematic Review. J Natl Cancer Inst, 112(8), 779–791. https://doi.org/10.1093/jnci/djaa043Full Text Link to Item
-
Khera, N., Sugalski, J., Krause, D., Butterfield, R., Zhang, N., Stewart, F. M., … Lee, S. J. (2020). Current Practices for Screening and Management of Financial Distress at NCCN Member Institutions. J Natl Compr Canc Netw, 18(7), 825–831. https://doi.org/10.6004/jnccn.2020.7538Full Text Link to Item
-
Lou, E., Beg, S., Bergsland, E., Eng, C., Khorana, A., Kopetz, S., … Zafar, S. Y. (2020). Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient Risk. Jco Oncol Pract, 16(7), 383–388. https://doi.org/10.1200/OP.20.00239Full Text Link to Item
-
Zafar, S. Y., & Sanoff, H. K. (2020). Changing the Course of Cancer Care With Greater Precision. Jama Oncol, 6(5), 634–636. https://doi.org/10.1001/jamaoncol.2019.6843Full Text Link to Item
-
Lou, E., Beg, M. S., Bergsland, E., Eng, C., Khorana, A. A., Kopetz, S., … Zafar, S. Y. (2020). BRAF-Mutated Metastatic Colon Cancers During COVID-19 Pandemic Reply. Jco Oncology Practice, 16(8), 526-+.Link to Item
-
Tran, G., Harker, M., Chiswell, K., Unger, J. M., Fleury, M. E., Hirsch, B., … Zafar, S. Y. (2020). Feasibility of Cancer Clinical Trial Enrollment Goals Based on Cancer Incidence. Jco Clin Cancer Inform, 4, 35–49. https://doi.org/10.1200/CCI.19.00088Full Text Link to Item
-
Strickler, J. H., Rushing, C. N., Niedzwiecki, D., McLeod, A., Altomare, I., Uronis, H. E., … Hurwitz, H. I. (2019). A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer. Bmc Cancer, 19(1), 1032. https://doi.org/10.1186/s12885-019-6234-8Full Text Link to Item
-
Clarke, J. M., Blobe, G. C., Strickler, J. H., Uronis, H. E., Zafar, S. Y., Morse, M., … Hurwitz, H. I. (2019). A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial). Cancer Chemother Pharmacol, 84(4), 909–917. https://doi.org/10.1007/s00280-019-03916-0Full Text Link to Item
-
Greenup, R. A., Rushing, C., Fish, L., Campbell, B. M., Tolnitch, L., Hyslop, T., … Hwang, E. S. (2019). Financial Costs and Burden Related to Decisions for Breast Cancer Surgery. J Oncol Pract, 15(8), e666–e676. https://doi.org/10.1200/JOP.18.00796Full Text Link to Item
-
Zullig, L. L., Ramos, K., Berkowitz, C., Miller, J. J., Dolor, R. J., Koontz, B. F., … Bosworth, H. B. (2019). Assessing Key Stakeholders' Knowledge, Needs, and Preferences for Head and Neck Cancer Survivorship Care Plans. J Cancer Educ, 34(3), 584–591. https://doi.org/10.1007/s13187-018-1345-5Full Text Link to Item
-
Chino, F., & Zafar, S. Y. (2019). Financial Toxicity and Equitable Access to Clinical Trials. Am Soc Clin Oncol Educ Book, 39, 11–18. https://doi.org/10.1200/EDBK_100019Full Text Link to Item
-
Chino, F., Kamal, A. H., Leblanc, T. W., Zafar, S. Y., Suneja, G., & Chino, J. P. (2018). Place of death for patients with cancer in the United States, 1999 through 2015: Racial, age, and geographic disparities. Cancer, 124(22), 4408–4419. https://doi.org/10.1002/cncr.31737Full Text Link to Item
-
Zafar, S. Y., Polite, B. N., & McClellan, M. (2018). Engaging Patients in Value-Based Cancer Care: A Missed Opportunity. Jama Oncol, 4(11), 1479–1480. https://doi.org/10.1001/jamaoncol.2018.2826Full Text Link to Item
-
Sitlinger, A., & Zafar, S. Y. (2018). Health-Related Quality of Life: The Impact on Morbidity and Mortality. Surg Oncol Clin N Am, 27(4), 675–684. https://doi.org/10.1016/j.soc.2018.05.008Full Text Link to Item
-
Chino, F., Peppercorn, J. M., Rushing, C., Nicolla, J., Kamal, A. H., Altomare, I., … Zafar, S. Y. (2018). Going for Broke: A Longitudinal Study of Patient-Reported Financial Sacrifice in Cancer Care. J Oncol Pract, 14(9), e533–e546. https://doi.org/10.1200/JOP.18.00112Full Text Link to Item
-
Hastert, T. A., Young, G. S., Pennell, M. L., Padamsee, T., Zafar, S. Y., DeGraffinreid, C., … Paskett, E. D. (2018). Financial burden among older, long-term cancer survivors: Results from the LILAC study. Cancer Med, 7(9), 4261–4272. https://doi.org/10.1002/cam4.1671Full Text Link to Item
-
Leopold, C., Peppercorn, J. M., Zafar, S. Y., & Wagner, A. K. (2018). Defining Value of Cancer Therapeutics-A Health System Perspective. J Natl Cancer Inst, 110(7), 699–703. https://doi.org/10.1093/jnci/djy079Full Text Link to Item
-
Vlahovic, G., Meadows, K. L., Hatch, A. J., Jia, J., Nixon, A. B., Uronis, H. E., … Hurwitz, H. I. (2018). A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer. Oncologist, 23(7), 782–790. https://doi.org/10.1634/theoncologist.2016-0377Full Text Link to Item
-
Chan, R. J., Gordon, L., Zafar, S. Y., & Miaskowski, C. (2018). Financial toxicity and symptom burden: what is the big deal? Support Care Cancer, 26(5), 1357–1359. https://doi.org/10.1007/s00520-018-4092-6Full Text Link to Item
-
Tran, G., & Zafar, S. Y. (2018). Financial toxicity and implications for cancer care in the era of molecular and immune therapies. Ann Transl Med, 6(9), 166. https://doi.org/10.21037/atm.2018.03.28Full Text Link to Item
-
Shih, Y.-C., Nasso, S. F., & Zafar, S. Y. (2018). Price Transparency for Whom? In Search of Out-of-Pocket Cost Estimates to Facilitate Cost Communication in Cancer Care. Pharmacoeconomics, 36(3), 259–261. https://doi.org/10.1007/s40273-018-0613-xFull Text Link to Item
-
Tran, G., & Zafar, S. Y. (2018). Price of Cancer Care and Its Tax on Quality of Life. J Oncol Pract, 14(2), 69–71. https://doi.org/10.1200/JOP.2017.028498Full Text Link to Item
-
Moss, H. A., Havrilesky, L. J., Zafar, S. Y., Suneja, G., & Chino, J. (2018). Trends in Insurance Status Among Patients Diagnosed With Cancer Before and After Implementation of the Affordable Care Act. J Oncol Pract, 14(2), e92–e102. https://doi.org/10.1200/JOP.2017.027102Full Text Link to Item
-
Williams, G. R. (2018). Geriatric Assessment: Precision Medicine for Older Adults With Cancer. Journal of Oncology Practice, 14(2), 97–98. https://doi.org/10.1200/jop.18.00010Full Text
-
Sitlinger, A. P., & Zafar, S. Y. (2018). With Colorectal Cancer Treatment, Physical Toxicity Is Not the Only Concern. Dis Colon Rectum, 61(1), 4–5. https://doi.org/10.1097/DCR.0000000000000922Full Text Link to Item
-
Langer, S. L., Romano, J. M., Todd, M., Strauman, T. J., Keefe, F. J., Syrjala, K. L., … Porter, L. S. (2018). Links Between Communication and Relationship Satisfaction Among Patients With Cancer and Their Spouses: Results of a Fourteen-Day Smartphone-Based Ecological Momentary Assessment Study. Front Psychol, 9, 1843. https://doi.org/10.3389/fpsyg.2018.01843Full Text Open Access Copy Link to Item
-
Sloan, C., & Zafar, S. Y. (2018). Ask Early and Ask Often: How Discussing Costs Could Save Your Patient's Life. N C Med J, 79(1), 39–42. https://doi.org/10.18043/ncm.79.1.39Full Text Link to Item
-
Hunter, W. G., Zafar, S. Y., Hesson, A., Davis, J. K., Kirby, C., Barnett, J. A., & Ubel, P. A. (2017). Discussing Health Care Expenses in the Oncology Clinic: Analysis of Cost Conversations in Outpatient Encounters. J Oncol Pract, 13(11), e944–e956. https://doi.org/10.1200/JOP.2017.022855Full Text Link to Item
-
Chino, F., Peppercorn, J. M., Rushing, C., Kamal, A. H., Altomare, I., Samsa, G., & Zafar, S. Y. (2017). Out-of-Pocket Costs, Financial Distress, and Underinsurance in Cancer Care. Jama Oncol, 3(11), 1582–1584. https://doi.org/10.1001/jamaoncol.2017.2148Full Text Link to Item
-
Porter, L. S., Keefe, F. J., Baucom, D. H., Olsen, M., Zafar, S. Y., & Uronis, H. (2017). A randomized pilot trial of a videoconference couples communication intervention for advanced GI cancer. Psychooncology, 26(7), 1027–1035. https://doi.org/10.1002/pon.4121Full Text Link to Item
-
Zafar, S. Y., & Peppercorn, J. M. (2017). Patient Financial Assistance Programs: A Path to Affordability or a Barrier to Accessible Cancer Care? J Clin Oncol, 35(19), 2113–2116. https://doi.org/10.1200/JCO.2016.71.7280Full Text Link to Item
-
Mowery, Y. M., Salama, J. K., Zafar, S. Y., Moore, H. G., Willett, C. G., Czito, B. G., … Palta, M. (2017). Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States. Cancer, 123(8), 1434–1441. https://doi.org/10.1002/cncr.30461Full Text Link to Item
-
Zullig, L. L., Wolf, S., Vlastelica, L., Shankaran, V., & Zafar, S. Y. (2017). The Role of Patient Financial Assistance Programs in Reducing Costs for Cancer Patients. J Manag Care Spec Pharm, 23(4), 407–411. https://doi.org/10.18553/jmcp.2017.23.4.407Full Text Link to Item
-
Zafar, S. Y., Peppercorn, J., Asabere, A., & Bastian, A. (2017). Transparency of Industry-Sponsored Oncology Patient Financial Assistance Programs Using a Patient-Centered Approach. J Oncol Pract, 13(3), e240–e248. https://doi.org/10.1200/JOP.2016.017509Full Text Link to Item
-
Zafar, S. Y., Newcomer, L. N., McCarthy, J., Fuld Nasso, S., & Saltz, L. B. (2017). How Should We Intervene on the Financial Toxicity of Cancer Care? One Shot, Four Perspectives. Am Soc Clin Oncol Educ Book, 37, 35–39. https://doi.org/10.1200/EDBK_174893Full Text Link to Item
-
Zullig, L. L., Schroeder, K., Nyindo, P., Namwai, T., Silayo, E., Msomba, A., … Zafar, S. Y. (2016). Validation and Quality Assessment of the Kilimanjaro Cancer Registry. J Glob Oncol, 2(6), 381–386. https://doi.org/10.1200/JGO.2015.002873Full Text Open Access Copy Link to Item
-
Chino, F., Peppercorn, J. M., Rushing, C., Samsa, G., Nicolla, J., Altomare, I., & Zafar, S. Y. (2016). "Going for Broke": Out-of-Pocket Costs, Financial Distress, and Patient-Reported Willingness to Pay and Sacrifice in Cancer Care. Int J Radiat Oncol Biol Phys, 96(2S), S135–S136. https://doi.org/10.1016/j.ijrobp.2016.06.330Full Text Link to Item
-
Mowery, Y. M., Salama, J. K., Zafar, S. Y., Moore, H. G., Willett, C. G., Czito, B., … Palta, M. (2016). Radiation Oncologists' Practice Patterns and Attitudes Regarding Neoadjuvant Short-Course Radiation Therapy for Rectal Cancer in the United States. Int J Radiat Oncol Biol Phys, 96(2S), S203. https://doi.org/10.1016/j.ijrobp.2016.06.505Full Text Link to Item
-
Wollins, D. S., & Zafar, S. Y. (2016). A Touchy Subject: Can Physicians Improve Value by Discussing Costs and Clinical Benefits With Patients? Oncologist, 21(10), 1157–1160. https://doi.org/10.1634/theoncologist.2016-0207Full Text Link to Item
-
Hochman, M. J., Wolf, S., Zafar, S. Y., Portman, D., Bull, J., & Kamal, A. H. (2016). Comparing Unmet Needs to Optimize Quality: Characterizing Inpatient and Outpatient Palliative Care Populations. J Pain Symptom Manage, 51(6), 1033-1039.e3. https://doi.org/10.1016/j.jpainsymman.2015.12.338Full Text Link to Item
-
Nipp, R. D., Zullig, L. L., Samsa, G., Peppercorn, J. M., Schrag, D., Taylor, D. H., … Zafar, S. Y. (2016). Identifying cancer patients who alter care or lifestyle due to treatment-related financial distress. Psychooncology, 25(6), 719–725. https://doi.org/10.1002/pon.3911Full Text Link to Item
-
Lathan, C. S., Cronin, A., Tucker-Seeley, R., Zafar, S. Y., Ayanian, J. Z., & Schrag, D. (2016). Association of Financial Strain With Symptom Burden and Quality of Life for Patients With Lung or Colorectal Cancer. J Clin Oncol, 34(15), 1732–1740. https://doi.org/10.1200/JCO.2015.63.2232Full Text Link to Item
-
Zafar, S. Y. (2016). Financial Toxicity of Cancer Care: It's Time to Intervene. J Natl Cancer Inst, 108(5). https://doi.org/10.1093/jnci/djv370Full Text Link to Item
-
Altomare, I., Irwin, B., Zafar, S. Y., Houck, K., Maloney, B., Greenup, R., & Peppercorn, J. (2016). Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care. J Oncol Pract, 12(3), e281-248. https://doi.org/10.1200/JOP.2015.007401Full Text Link to Item
-
Roe, M. T., Cyr, D. D., Eckart, D., Schulte, P. J., Morse, M. A., Blackwell, K. L., … TRILOGY ACS Investigators, . (2016). Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome. Eur Heart J, 37(4), 412–422. https://doi.org/10.1093/eurheartj/ehv611Full Text Link to Item
-
Kircher, S. M., Meeker, C. R., Nimeiri, H., Geynisman, D. M., Zafar, S. Y., Shankaran, V., … Wong, Y.-N. (2016). The Parity Paradigm: Can Legislation Help Reduce the Cost Burden of Oral Anticancer Medications? Value Health, 19(1), 88–98. https://doi.org/10.1016/j.jval.2015.10.005Full Text Link to Item
-
Deming, D., Uboha, N., Zafar, S. Y., Rosenberg, S., Bassetti, M., Glasgow, S., … Lubner, S. (2015). Adjuvant Chemotherapy for Stage II Rectal Cancer. Semin Oncol, 42(6), e99-107. https://doi.org/10.1053/j.seminoncol.2015.09.033Full Text Link to Item
-
Zafar, S. Y., Chino, F., Ubel, P. A., Rushing, C., Samsa, G., Altomare, I., … Peppercorn, J. M. (2015). The utility of cost discussions between patients with cancer and oncologists. Am J Manag Care, 21(9), 607–615.Link to Item
-
Nipp, R. D., Currow, D. C., Cherny, N. I., Strasser, F., Abernethy, A. P., & Zafar, S. Y. (2015). Best supportive care in clinical trials: review of the inconsistency in control arm design. Br J Cancer, 113(1), 6–11. https://doi.org/10.1038/bjc.2015.192Full Text Link to Item
-
Kutner, J. S., Blatchford, P. J., Taylor, D. H., Ritchie, C. S., Bull, J. H., Fairclough, D. L., … Abernethy, A. P. (2015). Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. Jama Intern Med, 175(5), 691–700. https://doi.org/10.1001/jamainternmed.2015.0289Full Text Link to Item
-
Zafar, S. Y., Ubel, P. A., Tulsky, J. A., & Pollak, K. I. (2015). Cost-related health literacy: a key component of high-quality cancer care. J Oncol Pract, 11(3), 171–173. https://doi.org/10.1200/JOP.2015.004408Full Text Link to Item
-
Zafar, S. Y., McNeil, R. B., Thomas, C. M., Lathan, C. S., Ayanian, J. Z., & Provenzale, D. (2015). Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study. J Oncol Pract, 11(2), 145–150. https://doi.org/10.1200/JOP.2014.001542Full Text Link to Item
-
Corrigendum. (2015). Future Oncol, 11(3), 544. https://doi.org/10.2217/fon.14.304Full Text Link to Item
-
Kasi, P. M., Zafar, S. Y., & Grothey, A. (2015). Is obesity an advantage in patients with colorectal cancer? Expert Rev Gastroenterol Hepatol, 9(11), 1339–1342. https://doi.org/10.1586/17474124.2015.1089170Full Text Link to Item
-
Bestvina, C. M., Zullig, L. L., & Yousuf Zafar, S. (2014). The implications of out-of-pocket cost of cancer treatment in the USA: a critical appraisal of the literature. Future Oncol, 10(14), 2189–2199. https://doi.org/10.2217/fon.14.130Full Text Link to Item
-
Taylor, D. H., Danis, M., Zafar, S. Y., Howie, L. J., Samsa, G. P., Wolf, S. P., & Abernethy, A. P. (2014). There is a mismatch between the medicare benefit package and the preferences of patients with cancer and their caregivers. J Clin Oncol, 32(28), 3163–3168. https://doi.org/10.1200/JCO.2013.54.2605Full Text Link to Item
-
Smith, S. K., Nicolla, J., & Zafar, S. Y. (2014). Bridging the gap between financial distress and available resources for patients with cancer: a qualitative study. J Oncol Pract, 10(5), e368–e372. https://doi.org/10.1200/JOP.2013.001342Full Text Link to Item
-
Rangwala, F., Bendell, J. C., Kozloff, M. F., Arrowood, C. C., Dellinger, A., Meadows, J., … Hurwitz, H. I. (2014). Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors. Invest New Drugs, 32(4), 700–709. https://doi.org/10.1007/s10637-014-0089-2Full Text Link to Item
-
Danis, M., Abernethy, A. P., Zafar, S. Y., Samsa, G. P., Wolf, S. P., Howie, L., & Taylor, D. H. (2014). A decision exercise to engage cancer patients and families in deliberation about Medicare coverage for advanced cancer care. Bmc Health Serv Res, 14, 315. https://doi.org/10.1186/1472-6963-14-315Full Text Link to Item
-
Zafar, S. Y., Tulsky, J. A., & Abernethy, A. P. (2014). It's time to have 'the talk': cost communication and patient-centered care. Oncology (Williston Park), 28(6), 479–480.Link to Item
-
De Boer, C., Niyonzima, N., Orem, J., Bartlett, J., & Zafar, S. Y. (2014). Prognosis and delay of diagnosis among Kaposi's sarcoma patients in Uganda: A cross-sectional study. Infectious Agents and Cancer, 9(1). https://doi.org/10.1186/1750-9378-9-17Full Text
-
Bestvina, C. M., Zullig, L. L., Rushing, C., Chino, F., Samsa, G. P., Altomare, I., … Zafar, S. Y. (2014). Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract, 10(3), 162–167. https://doi.org/10.1200/JOP.2014.001406Full Text Link to Item
-
Chino, F., Peppercorn, J., Taylor, D. H., Lu, Y., Samsa, G., Abernethy, A. P., & Zafar, S. Y. (2014). Self-reported financial burden and satisfaction with care among patients with cancer. Oncologist, 19(4), 414–420. https://doi.org/10.1634/theoncologist.2013-0374Full Text Link to Item
-
Strickler, J. H., McCall, S., Nixon, A. B., Brady, J. C., Pang, H., Rushing, C., … Hurwitz, H. I. (2014). Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer. Invest New Drugs, 32(2), 330–339. https://doi.org/10.1007/s10637-013-0042-9Full Text Link to Item
-
van Ryn, M., Phelan, S. M., Arora, N. K., Haggstrom, D. A., Jackson, G. L., Zafar, S. Y., … Clauser, S. B. (2014). Patient-reported quality of supportive care among patients with colorectal cancer in the Veterans Affairs Health Care System. J Clin Oncol, 32(8), 809–815. https://doi.org/10.1200/JCO.2013.49.4302Full Text Link to Item
-
Peppercorn, J., Zafar, S. Y., Houck, K., Ubel, P., & Meropol, N. J. (2014). Does comparative effectiveness research promote rationing of cancer care? Lancet Oncol, 15(3), e132–e138. https://doi.org/10.1016/S1470-2045(13)70597-7Full Text Link to Item
-
Bartley, A. N., Hamilton, S. R., Alsabeh, R., Ambinder, E. P., Berman, M., Collins, E., … Members of the Cancer Biomarker Reporting Workgroup, College of American Pathologists, . (2014). Template for reporting results of biomarker testing of specimens from patients with carcinoma of the colon and rectum. Arch Pathol Lab Med, 138(2), 166–170. https://doi.org/10.5858/arpa.2013-0231-CPFull Text Link to Item
-
Peppercorn, J., Zafar, S. Y., Houck, K., Ubel, P., & Meropol, N. J. (2014). Does comparative effectiveness research promote rationing of cancer care? The Lancet Oncology, 15(3), e132–e138.
-
Yousuf Zafar, S., Tulsky, J. A., & Abernethy, A. P. (2014). It's time to have 'The talk': Cost communication and patient-centered care. Oncology (United States), 28(6), 13.
-
De Boer, C., Niyonzima, N., Orem, J., Bartlett, J., & Zafar, S. Y. (2014). Prognosis and delay of diagnosis among Kaposi's sarcoma patients in Uganda: a cross-sectional study. Infect Agent Cancer, 9, 17. https://doi.org/10.1186/1750-9378-9-17Full Text Link to Item
-
Hirsch, B. R., & Zafar, S. Y. (2014). Comparative effectiveness research: moving medical oncology forward. Semin Radiat Oncol, 24(1), 49–53. https://doi.org/10.1016/j.semradonc.2013.08.005Full Text Link to Item
-
Zullig, L. L., Peppercorn, J. M., Schrag, D., Taylor, D. H., Lu, Y., Samsa, G., … Zafar, S. Y. (2013). Financial Distress, Use of Cost-Coping Strategies, and Adherence to Prescription Medication Among Patients With Cancer. J Oncol Pract, 9(6S), 60s-63s. https://doi.org/10.1200/JOP.2013.000971Full Text Link to Item
-
Ubel, P. A., Abernethy, A. P., & Zafar, S. Y. (2013). Full disclosure--out-of-pocket costs as side effects. N Engl J Med, 369(16), 1484–1486. https://doi.org/10.1056/NEJMp1306826Full Text Link to Item
-
Jackson, G. L., Zullig, L. L., Zafar, S. Y., Powell, A. A., Ordin, D. L., Gellad, Z. F., … Provenzale, D. (2013). Using NCCN clinical practice guidelines in oncology to measure the quality of colorectal cancer care in the veterans health administration. J Natl Compr Canc Netw, 11(4), 431–441. https://doi.org/10.6004/jnccn.2013.0058Full Text Link to Item
-
Zafar, S. Y., & Abernethy, A. P. (2013). Financial toxicity, Part II: how can we help with the burden of treatment-related costs? Oncology (Williston Park), 27(4), 253–256.Link to Item
-
Fouad, M. N., Lee, J. Y., Catalano, P. J., Vogt, T. M., Zafar, S. Y., West, D. W., … Kiefe, C. I. (2013). Enrollment of patients with lung and colorectal cancers onto clinical trials. J Oncol Pract, 9(2), e40–e47. https://doi.org/10.1200/JOP.2012.000598Full Text Link to Item
-
Zafar, S. Y., Malin, J. L., Grambow, S. C., Abbott, D. H., Kolimaga, J. T., Zullig, L. L., … Cancer Care Outcomes Research & Surveillance CanCORS Consortium, . (2013). Chemotherapy use and patient treatment preferences in advanced colorectal cancer: a prospective cohort study. Cancer, 119(4), 854–862. https://doi.org/10.1002/cncr.27815Full Text Link to Item
-
Zafar, S. Y., & Abernethy, A. P. (2013). Financial toxicity, Part I: a new name for a growing problem. Oncology (Williston Park), 27(2), 80–149.Link to Item
-
Zafar, S. Y., & Abernethy, A. P. (2013). Financial toxicity, Part I: a new name for a growing problem. Oncology (Williston Park, N.Y.), 27(2).
-
Zafar, S. Y., & Abernethy, A. P. (2013). Financial toxicity, Part II: how can we help with the burden of treatment-related costs? Oncology (Williston Park, N.Y.), 27(4).
-
Phelan, S. M., Griffin, J. M., Jackson, G. L., Zafar, S. Y., Hellerstedt, W., Stahre, M., … van Ryn, M. (2013). Stigma, perceived blame, self-blame, and depressive symptoms in men with colorectal cancer. Psychooncology, 22(1), 65–73. https://doi.org/10.1002/pon.2048Full Text Link to Item
-
Uronis, H. E., Bendell, J. C., Altomare, I., Blobe, G. C., Hsu, S. D., Morse, M. A., … Hurwitz, H. I. (2013). A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas. Oncologist, 18(3), 271–272. https://doi.org/10.1634/theoncologist.2012-0404Full Text Link to Item
-
Zafar, S. Y., Peppercorn, J. M., Schrag, D., Taylor, D. H., Goetzinger, A. M., Zhong, X., & Abernethy, A. P. (2013). The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist, 18(4), 381–390. https://doi.org/10.1634/theoncologist.2012-0279Full Text Link to Item
-
Zullig, L. L., Muiruri, C., Abernethy, A., Weiner, B. J., Bartlett, J., Oneko, O., & Zafar, S. Y. (2013). Cancer registration needs assessment at a tertiary medical centre in Kilimanjaro, Tanzania. World Health Popul, 14(2), 12–23. https://doi.org/10.12927/whp.2013.23271Full Text Link to Item
-
Roe, M. T., Armstrong, P. W., Fox, K. A. A., White, H. D., Prabhakaran, D., Goodman, S. G., … TRILOGY ACS Investigators, . (2012). Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med, 367(14), 1297–1309. https://doi.org/10.1056/NEJMoa1205512Full Text Link to Item
-
Strickler, J. H., Starodub, A. N., Jia, J., Meadows, K. L., Nixon, A. B., Dellinger, A., … Hurwitz, H. I. (2012). Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors. Cancer Chemother Pharmacol, 70(2), 251–258. https://doi.org/10.1007/s00280-012-1911-1Full Text Link to Item
-
Vlahovic, G., Meadows, K. L., Uronis, H. E., Morse, M. A., Blobe, G. C., Riedel, R. F., … Hurwitz, H. I. (2012). A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors. Cancer Chemother Pharmacol, 70(1), 95–102. https://doi.org/10.1007/s00280-012-1889-8Full Text Link to Item
-
Currow, D. C., Tieman, J. J., Greene, A., Zafar, S. Y., Wheeler, J. L., & Abernethy, A. P. (2012). Refining a checklist for reporting patient populations and service characteristics in hospice and palliative care research. J Pain Symptom Manage, 43(5), 902–910. https://doi.org/10.1016/j.jpainsymman.2011.05.015Full Text Link to Item
-
Palta, M., Patel, P., Broadwater, G., Willett, C., Pepek, J., Tyler, D., … Czito, B. (2012). Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy. Ann Surg Oncol, 19(5), 1535–1540. https://doi.org/10.1245/s10434-011-2117-1Full Text Link to Item
-
Rangwala, F., Zafar, S. Y., & Abernethy, A. P. (2012). Gastrointestinal symptoms in cancer patients with advanced disease: new methodologies, insights, and a proposed approach. Curr Opin Support Palliat Care, 6(1), 69–76. https://doi.org/10.1097/SPC.0b013e32834f689dFull Text Link to Item
-
Zafar, S. Y., Currow, D. C., Cherny, N., Strasser, F., Fowler, R., & Abernethy, A. P. (2012). Consensus-based standards for best supportive care in clinical trials in advanced cancer. Lancet Oncol, 13(2), e77–e82. https://doi.org/10.1016/S1470-2045(11)70215-7Full Text Link to Item
-
Zafar, S. Y., Malin, J. L., Grambow, S. C., Abbott, D. H., Schrag, D., Kolimaga, J. T., … Cancer Care and Outcomes Research and Surveillance (CanCORS) Consortium, . (2011). Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study. Bmc Cancer, 11, 354. https://doi.org/10.1186/1471-2407-11-354Full Text Link to Item
-
Bullock, K. E., Petros, W. P., Younis, I., Uronis, H. E., Morse, M. A., Blobe, G. C., … Bendell, J. C. (2011). A phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE). Cancer Chemother Pharmacol, 67(2), 465–474. https://doi.org/10.1007/s00280-010-1507-6Full Text Link to Item
-
Currow, D. C., Foley, K., Zafar, S. Y., Wheeler, J. L., & Abernethy, A. P. (2011). The need for a re-evaluation of best supportive care studies reported to date. Br J Cancer, 104(3), 390–391. https://doi.org/10.1038/sj.bjc.6606081Full Text Link to Item
-
Altomare, I., Bendell, J. C., Bullock, K. E., Uronis, H. E., Morse, M. A., Hsu, S. D., … Hurwitz, H. I. (2011). A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer. Oncologist, 16(8), 1131–1137. https://doi.org/10.1634/theoncologist.2011-0078Full Text Link to Item
-
Hirsch, B. R., & Zafar, S. Y. (2011). Capecitabine in the management of colorectal cancer. Cancer Manag Res, 3, 79–89. https://doi.org/10.2147/CMR.S11250Full Text Link to Item
-
Abernethy, A. P., Aziz, N. M., Basch, E., Bull, J., Cleeland, C. S., Currow, D. C., … Kutner, J. S. (2010). A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group. J Palliat Med, 13(12), 1407–1413. https://doi.org/10.1089/jpm.2010.0261Full Text Open Access Copy Link to Item
-
Abernethy, A. P., Zafar, S. Y., Uronis, H., Wheeler, J. L., Coan, A., Rowe, K., … Herndon, J. E. (2010). Validation of the Patient Care Monitor (Version 2.0): a review of system assessment instrument for cancer patients. J Pain Symptom Manage, 40(4), 545–558. https://doi.org/10.1016/j.jpainsymman.2010.01.017Full Text Link to Item
-
Bull, J., Zafar, S. Y., Wheeler, J. L., Harker, M., Gblokpor, A., Hanson, L., … Abernethy, A. P. (2010). Establishing a regional, multisite database for quality improvement and service planning in community-based palliative care and hospice. J Palliat Med, 13(8), 1013–1020. https://doi.org/10.1089/jpm.2010.0017Full Text Open Access Copy Link to Item
-
Jackson, G. L., Melton, L. D., Abbott, D. H., Zullig, L. L., Ordin, D. L., Grambow, S. C., … Provenzale, D. (2010). Quality of nonmetastatic colorectal cancer care in the Department of Veterans Affairs. J Clin Oncol, 28(19), 3176–3181. https://doi.org/10.1200/JCO.2009.26.7948Full Text Link to Item
-
Abernethy, A. P., Ahmad, A., Zafar, S. Y., Wheeler, J. L., Reese, J. B., & Lyerly, H. K. (2010). Electronic patient-reported data capture as a foundation of rapid learning cancer care. Med Care, 48(6 Suppl), S32–S38. https://doi.org/10.1097/MLR.0b013e3181db53a4Full Text Link to Item
-
Abernethy, A. P., Wheeler, J. L., & Zafar, S. Y. (2010). Management of gastrointestinal symptoms in advanced cancer patients: the rapid learning cancer clinic model. Curr Opin Support Palliat Care, 4(1), 36–45. https://doi.org/10.1097/SPC.0b013e32833575fdFull Text Link to Item
-
Chrischilles, E. A., Pendergast, J. F., Kahn, K. L., Wallace, R. B., Moga, D. C., Harrington, D. P., … Fletcher, R. H. (2010). Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol, 28(4), 620–627. https://doi.org/10.1200/JCO.2009.23.8485Full Text Link to Item
-
Zafar, S. Y., Currow, D. C., Daugherty, C. K., & Abernethy, A. P. (2010). Standards for palliative care delivery in oncology settings. Cancer J, 16(5), 436–443. https://doi.org/10.1097/PPO.0b13e3181f289f7Full Text Link to Item
-
Zafar, S. Y., Marcello, J. E., Wheeler, J. L., Rowe, K. L., Morse, M. A., Herndon, J. E., & Abernethy, A. P. (2010). Treatment-related toxicity and supportive care in metastatic colorectal cancer. J Support Oncol, 8(1), 15–20.Link to Item
-
Cherny, N. I., Abernethy, A. P., Strasser, F., Sapir, R., Currow, D., & Zafar, S. Y. (2009). Improving the methodologic and ethical validity of best supportive care studies in oncology: lessons from a systematic review. J Clin Oncol, 27(32), 5476–5486. https://doi.org/10.1200/JCO.2009.21.9592Full Text Link to Item
-
Zafar, S. Y., Marcello, J. E., Wheeler, J. L., Rowe, K. L., Morse, M. A., Herndon, J. E., & Abernethy, A. P. (2009). Longitudinal patterns of chemotherapy use in metastatic colorectal cancer. J Oncol Pract, 5(5), 228–233. https://doi.org/10.1200/JOP.091010Full Text Link to Item
-
Abernethy, A. P., Barbour, S. Y., Uronis, H., Zafar, S. Y., Coan, A., Rowe, K., … Herndon, J. E. (2009). Quality management of potential chemotherapy-induced neutropenic complications: evaluation of practice in an academic medical center. Support Care Cancer, 17(6), 735–744. https://doi.org/10.1007/s00520-008-0562-6Full Text Link to Item
-
Abernethy, A. P., Zafar, S. Y., Coeytaux, R., Rowe, K., Wheeler, J. L., & Lyerly, H. K. (2009). Electronic patient-reported data capture as the foundation of a learning health care system. J Clin Oncol, 27(15_suppl), 6522.Link to Item
-
Bullock, K. E., Hurwitz, H. I., Uronis, H. E., Morse, M. A., Blobe, G. C., Hsu, S. D., … Bendell, J. C. (2009). Bevacizumab (B) plus everolimus (E) in refractory metastatic colorectal cancer (mCRC). J Clin Oncol, 27(15_suppl), 4080.Link to Item
-
Abernethy, A. P., Wheeler, J. L., & Zafar, S. Y. (2009). Detailing of gastrointestinal symptoms in cancer patients with advanced disease: new methodologies, new insights, and a proposed approach. Curr Opin Support Palliat Care, 3(1), 41–49. https://doi.org/10.1097/SPC.0b013e32832531ceFull Text Link to Item
-
Zafar, S. Y., Abernethy, A. P., & Currow, D. (2009). To the editor. Journal of Clinical Oncology, 27(5), 829. https://doi.org/10.1200/JCO.2008.20.6029Full Text
-
Zafar, S. Y., Alexander, S. C., Weinfurt, K. P., Schulman, K. A., & Abernethy, A. P. (2009). Decision making and quality of life in the treatment of cancer: a review. Support Care Cancer, 17(2), 117–127. https://doi.org/10.1007/s00520-008-0505-2Full Text Link to Item
-
Dupont, A., Wheeler, J., Herndon, J. E., Coan, A., Zafar, S. Y., Hood, L., … Abernethy, A. P. (2009). Use of tablet personal computers for sensitive patient-reported information. J Support Oncol, 7(3), 91–97.Link to Item
-
Yousuf, S. Y., Abernethy, A. P., Abbott, D. H., Grambow, S. C., Marcello, J. E., Herndon, J. E., … Provenzale, D. T. (2008). Comorbidity, age, race and stage at diagnosis in colorectal cancer: A retrospective, parallel analysis of two health systems. Bmc Cancer, 8. https://doi.org/10.1186/1471-2407-8-345Full Text
-
Zafar, S. Y., Abernethy, A. P., Abbott, D. H., Grambow, S. C., Marcello, J. E., Herndon, J. E., … Provenzale, D. T. (2008). Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems. Bmc Cancer, 8, 345. https://doi.org/10.1186/1471-2407-8-345Full Text Open Access Copy Link to Item
-
Zafar, S. Y., Currow, D., & Abernethy, A. P. (2008). Defining best supportive care. J Clin Oncol, 26(31), 5139–5140. https://doi.org/10.1200/JCO.2008.19.7491Full Text Link to Item
-
Zafar, S. Y., Howell, D. N., & Gockerman, J. P. (2008). Malignancy after solid organ transplantation: an overview. Oncologist, 13(7), 769–778. https://doi.org/10.1634/theoncologist.2007-0251Full Text Link to Item
-
Zafar, Y., & Hurwitz, H. I. (2007). Monoclonal antibodies to EGFR: What does the future hold? Oncology, 21(8), 976–977.
-
Zafar, Y., & Hurwitz, H. I. (2007). Monoclonal antibodies to EGFR: What does the future hold? The Burtness article reviewed. Oncology New York, 21(8), 976–977.Link to Item
-
-
Conference Papers
-
Langer, S., Todd, M., Romano, J. M., Bolger, N., Bricker, J., Syrjala, K. L., … Porter, L. S. (2020). THE RELATIONSHIP INTIMACY MODEL OF COUPLE ADAPTATION TO CANCER: SUPPORT FROM A PROSPECTIVE, LONGITUDINAL, SMARTPHONE-ENABLED ECOLOGICAL MOMENTARY ASSESSMENT STUDY. In Annals of Behavioral Medicine (Vol. 54, pp. S142–S142).Link to Item
-
Greenup, R. A., Rushing, C. N., Fish, L. J., Lane, W. O., Peppercorn, J. M., Bellavance, E., … Hwang, E. S. (2019). Perspectives on the Costs of Cancer Care: A Survey of the American Society of Breast Surgeons. In Ann Surg Oncol (Vol. 26, pp. 3141–3151). United States. https://doi.org/10.1245/s10434-019-07594-3Full Text Link to Item
-
Chino, F., Suneja, G., Moss, H., Zafar, S. Y., Havrilesky, L., & Chino, J. (2018). Health Care Disparities in Cancer Patients Receiving Radiation: Changes in Insurance Status After Medicaid Expansion Under the Affordable Care Act. In Int J Radiat Oncol Biol Phys (Vol. 101, pp. 9–20). United States. https://doi.org/10.1016/j.ijrobp.2017.12.006Full Text Link to Item
-
Coronado, D. Y. S., Hahn, T., Albelda, R., Khera, N., Odejide, O. O., Soiffer, R. J., … Abel, G. A. (2017). Financial Burden and Patient-Reported Outcomes after Hematopoietic Cell Transplantation: Impact of Pre-Treatment Awareness of Transplant-Associated Costs. In Blood (Vol. 130). Atlanta, GA: AMER SOC HEMATOLOGY.Link to Item
-
Sitlinger, A., Sachdev, R., Anderson, D., & Zafar, S. Y. (2017). Insurance Design and Out-of-Pocket (OOP) Costs: a Comparison of Oral and Intravenous (IV) Treatment Plans for Chronic Lymphocytic Leukemia (CLL) in the Era of the Affordable Care Act (ACA). In Blood (Vol. 130). Atlanta, GA: AMER SOC HEMATOLOGY.Link to Item
-
Chino, F., Peppercorn, J. M., Rushing, C., Samsa, G., Nicolla, J., Altomare, I., & Zafar, S. Y. (2016). "Going for Broke": Out-of-Pocket Costs, Financial Distress, and Patient-Reported Willingness to Pay and Sacrifice in Cancer Care. In International Journal of Radiation Oncology Biology Physics (Vol. 96, pp. S135–S136).Link to Item
-
Mowery, Y. M., Salama, J. K., Zafar, S. Y., Moore, H. G., Willett, C. G., Czito, B., … Palta, M. (2016). Radiation Oncologists' Practice Patterns and Attitudes Regarding Neoadjuvant Short-Course Radiation Therapy for Rectal Cancer in the United States. In International Journal of Radiation Oncology Biology Physics (Vol. 96, pp. S203–S203).Link to Item
-
Zafar, S. Y. (2016). Abstract IA09: Intervening on the financial toxicity of cancer care. In Cancer Epidemiology, Biomarkers &Amp; Prevention (Vol. 25, pp. IA09–IA09). American Association for Cancer Research (AACR). https://doi.org/10.1158/1538-7755.disp15-ia09Full Text
-
Irwin, B., Kimmick, G., Altomare, I., Marcom, P. K., Houck, K., Zafar, S. Y., & Peppercorn, J. (2014). Patient experience and attitudes toward addressing the cost of breast cancer care. In Oncologist (Vol. 19, pp. 1135–1140). England. https://doi.org/10.1634/theoncologist.2014-0117Full Text Link to Item
-
Zafar, S. Y., Grothey, A., Bekaii-Saab, T., Bendell, J., Sherrill, B., Bennett, L., … Hurwitz, H. I. (2012). SURVIVAL AMONG METASTATIC COLORECTAL CANCER (MCRC) PATIENTS TREATED IN A RANDOMIZED CONTROLLED TRIAL (RCT) VS AN OBSERVATIONAL COHORT STUDY (OCS). In Annals of Oncology (Vol. 23, pp. 191–191). Vienna, AUSTRIA: OXFORD UNIV PRESS.Link to Item
-
Bullock, K. E., Hurwitz, H. I., Uronis, H. E., Morse, M. A., Blobe, G. C., Hsu, S. D., … Bendell, J. C. (2009). Bevacizumab (B) plus everolimus (E) in refractory metastatic colorectal cancer (mCRC). In Journal of Clinical Oncology (Vol. 27). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.Link to Item
-
Abernethy, A. P., Zafar, S. Y., Coeytaux, R., Rowe, K., Wheeler, J. L., & Lyerly, H. K. (2009). Electronic patient-reported data capture as the foundation of a learning health care system. In Journal of Clinical Oncology (Vol. 27). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.Link to Item
-
-
- Teaching & Mentoring
-
Recent Courses
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.